Periodic Reporting for period 4 - HIPGEN (Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial)

The HIPGEN project aimed at bringing the first regenerative therapy for improving recovery following a surgically treated injury to market approval. The focus of the HIPGEN trial were patients undergoing total or hemiarthroplasty after femoral neck fracture. These fractures...